129 related articles for article (PubMed ID: 18203307)
1. Alendronate-induced synovitis.
Gwynne Jones DP; Savage RL; Highton J
J Rheumatol; 2008 Mar; 35(3):537-8. PubMed ID: 18203307
[TBL] [Abstract][Full Text] [Related]
2. [Persistent polyarticular synovitis after treatment with alendronate].
Frederiksen L; Junker P; Brixen KT
Ugeskr Laeger; 2007 Apr; 169(17):1583-4. PubMed ID: 17484832
[TBL] [Abstract][Full Text] [Related]
3. Possible alendronate-induced polyarticular synovitis.
Gökkus K; Yazicioglu G; Sagtas E; Uyan A; Aydin AT
J Postgrad Med; 2016; 62(2):126-8. PubMed ID: 26767974
[TBL] [Abstract][Full Text] [Related]
4. Alendronate-induced asthma.
Isik A; Uras I; Uyar ME; Karakurt F; Kaftan O
Ann Pharmacother; 2009 Mar; 43(3):547-8. PubMed ID: 19261958
[No Abstract] [Full Text] [Related]
5. An esophageal ulcer mimicking advanced esophageal cancer in a patient on alendronate sodium treatment for osteoporosis.
Terashima T; Hiramatsu K; Shimatani A; Matsuda M; Ogino H; Satomura Y; Noda Y
Endoscopy; 2006; 38 Suppl 2():E37. PubMed ID: 17366400
[No Abstract] [Full Text] [Related]
6. Risedronate-induced arthritis.
Yemisci OU; Yalbuzdag SA; Karatas M
J Clin Rheumatol; 2010 Jun; 16(4):168-9. PubMed ID: 20414126
[TBL] [Abstract][Full Text] [Related]
7. Adverse cutaneous drug reaction to alendronate.
Brinkmeier T; Kügler K; Lepoittevin JP; Frosch PJ
Contact Dermatitis; 2007 Aug; 57(2):123-5. PubMed ID: 17627657
[No Abstract] [Full Text] [Related]
8. Upper gastrointestinal tolerability of alendronate sodium monohydrate 10 mg once daily in postmenopausal women: a 12-week, randomized, double-blind, placebo-controlled, exploratory study.
Adachi JD; Faraawi RY; O'Mahony MF; Nayar A; Massaad R; Evans JK; Yacik C
Clin Ther; 2009 Aug; 31(8):1747-53. PubMed ID: 19808133
[TBL] [Abstract][Full Text] [Related]
9. [Osteoporotic fracture in menopausal women: alendronate reduces the risk].
Bize R; Lamy O; Peytremann-Bridevaux I
Rev Med Suisse; 2008 Dec; 4(183):2703. PubMed ID: 19157286
[No Abstract] [Full Text] [Related]
10. What's the story with Fosamax? Recent reports have women wondering if they should stop taking this widely prescribed osteoporosis drug.
Harv Womens Health Watch; 2008 Nov; 16(3):1-2. PubMed ID: 19043857
[No Abstract] [Full Text] [Related]
11. Synovitis induced by alendronic acid can present as acute carpal tunnel syndrome.
Jones DG; Savage R; Highton J
BMJ; 2005 Jan; 330(7482):74. PubMed ID: 15637369
[No Abstract] [Full Text] [Related]
12. Bisphosphonates and low-impact femoral fractures: current evidence on alendronate-fracture risk.
Schneider JP
Geriatrics; 2009 Jan; 64(1):18-23. PubMed ID: 19256578
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous bilateral atypical femoral fractures after alendronate therapy.
Zafeiris CP; Stathopoulos IP; Kourkoumelis G; Gkikas E; Lyritis GP
J Musculoskelet Neuronal Interact; 2012 Dec; 12(4):262-4. PubMed ID: 23196269
[No Abstract] [Full Text] [Related]
14. Corneal graft rejection precipitated by uveitis secondary to alendronate sodium therapy.
Richards JC; Wiffen SJ
Cornea; 2006 Oct; 25(9):1100-1. PubMed ID: 17133063
[TBL] [Abstract][Full Text] [Related]
15. Use of alendronate and risk of incident atrial fibrillation in women.
Heckbert SR; Li G; Cummings SR; Smith NL; Psaty BM
Arch Intern Med; 2008 Apr; 168(8):826-31. PubMed ID: 18443257
[TBL] [Abstract][Full Text] [Related]
16. Alendronate- and risedronate-induced acute polyarthritis.
Uğurlar M
Osteoporos Int; 2016 Nov; 27(11):3383-3385. PubMed ID: 27376840
[TBL] [Abstract][Full Text] [Related]
17. A double-blinded head-to-head trial of minodronate and alendronate in women with postmenopausal osteoporosis.
Hagino H; Nishizawa Y; Sone T; Morii H; Taketani Y; Nakamura T; Itabashi A; Mizunuma H; Ohashi Y; Shiraki M; Minamide T; Matsumoto T
Bone; 2009 Jun; 44(6):1078-84. PubMed ID: 19264155
[TBL] [Abstract][Full Text] [Related]
18. [Atrial fibrillation during bisphosphonate therapy. side effects or coincidental finding?].
Ringe JD
MMW Fortschr Med; 2009 Mar; 151(10):7. PubMed ID: 19472655
[No Abstract] [Full Text] [Related]
19. Considering competing risks . . . Not all black and white.
Cauley JA; Ensrud KE
Arch Intern Med; 2008 Apr; 168(8):793-5. PubMed ID: 18443252
[No Abstract] [Full Text] [Related]
20. [Alendronate for the prevention and treatment of postmenopausal osteoporosis. A survey of a Cochrane review].
Eiken PA; Abrahamsen B
Ugeskr Laeger; 2009 Mar; 171(11):903-6. PubMed ID: 19278615
[No Abstract] [Full Text] [Related]
[Next] [New Search]